New Administrative Supplement Opportunities

Administrative Supplement Opportunities for ITCR Investigators:

  1. IMAT-ITCR Collaborations: NCI has an interest in spurring collaborations between ITCR investigators and PIs from a sister technology development program for new molecular and cellular analysis technology development (IMAT). we are inviting you to consider engaging an investigative team funded by the IMAT program that might offer some intriguing complementarity to your own technology development project. Submission of an informal Letter of Intent (LOI) submitted by interested collaborators is due on June 29, 2020. More information is available at IMAT-ITCR Collaborative Supplements.

  2. Adaptations to informatics tools or methods specifically linked to use cases involving childhood cancer data: The NCI Childhood Cancer Data Initiative (CCDI) is a federal investment focused on the critical need to collect, analyze, and share data to address the burden of cancer in children, adolescents, and young adults. A key goal of CCDI is to develop and enhance tools and methods to extract knowledge from data. In support of this goal, the NCI is announcing an opportunity for supplemental funding to ITCR investigators for adaptations to informatics tools or methods specifically linked to use cases involving childhood cancer data. Submission of an informal Letter of Intent (LOI) is due on June 29, 2020 More information is available at CCDI Supplement.

  3. Software Tools for Open Science (NOT-OD-20-073): Through these awards, the NIH Office of Data Science Strategy (ODSS) intends to help researchers who have developed scientifically valuable software to make tools sustainable, contribute to open science, and take advantage of new data science and computing paradigms. To be eligible, the parent award must be able to receive funds in FY2020 (Oct. 1, 2019 - Sept. 30, 2020) and not be in the final year or in a no-cost extension period at the time of the award. Applications are due by May 15, 2020.


The NCI-specific COVID-19 research NOSIs have now been published in the NIH Guide:

  1. NOT-CA-20-042   Notice of Special Interest (NOSI): National Cancer Institute Announcement Regarding Availability of Urgent Competitive Revision and Administrative Supplements on Coronavirus Disease 2019 (COVID-19)   

  2. NOT-CA-20-043   Notice of Special Interest (NOSI): National Cancer Institute Announcement regarding Availability of Competitive Revision SBIR/STTR Supplements on Coronavirus Disease 2019 (COVID-19)

  3. NOT-CA-20-054: Contributing to the Global COVID-19 Crisis Response by Allowing Some NCI-supported Projects to be Redirected to COVID-19-related Research During the Crisis

Publish Date:  Monday, April 20, 2020